Investment Summary |
|
|---|---|
| Date | 2012-01-31 |
| Target | AngioDynamics |
| Sector | Medical Products |
| Investor(s) | Avista Healthcare Partners |
| Deal Type | PIPE |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2005 |
| PE ASSETS | 8.0B USD |
| Size | Mega |
| Type | Sector Focused |
Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 26 of 56 |
| Sector: Medical Products M&A | 5 of 11 |
| Type: PIPE M&A Deals | 1 of 2 |
| State: New York M&A | 2 of 3 |
| Country: United States M&A | 21 of 44 |
| Year: 2012 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-01-31 |
BioReliance
Rockville, Maryland, United States BioReliance provides critical services that include biologic, specialized toxicology and animal health testing to pharmaceutical, biopharmaceutical, diagnostics, and other life science customers worldwide. |
Sell | $350M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-05-02 |
Fougera Pharmaceuticals
Melville, New York, United States Fougera Pharmaceuticals Inc. operates two primary divisions in the US focused on specialty pharmaceuticals in dermatology: Fougera, its generic dermatology medicines business, and PharmaDerm, its branded dermatology business. Founded in 1849, the Fougera division is the leading manufacturer and distributor of a wide range of topical products. The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin – the largest organ of the human body. |
Sell | $1.5B |
